Table 2 Baseline characteristics of AS patients and healthy controls
Property | AS patients (n = 20) | Healthy controls (n = 20) |
|---|---|---|
Male/ Female | 15/5 (75%/25%) | 15/5 (75%/25%) |
Age | 35 ± 11.3 | 36 ± 7.4 |
BASDAI | 6.4 ± 2 | – |
BASFI | 4.5 ± 2.6 | – |
BASMI | 3.2 ± 1.2 | – |
Disease duration | 8.7 ± 9.8 | – |
HLA-B27 positive | 80% | 0 |
ESR | 29.3 ± 25.2 | – |
ASQol | 9.6 ± 4.8 | – |